42841002: Zinc oxide (substance)

SNOMED CT Concept\Substance\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Metal and/or metal compound\Heavy metal and/or heavy metal compound\Zinc and/or zinc compound (substance)\Zinc compound\Zinc oxide

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

71494010 Zinc oxide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

779786013 Zinc oxide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3254891000005112 zinkoxid da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Zinc oxide	Is a	solbeskyttelsesmiddel	false	Inferred relationship	Some
Zinc oxide	Is a	Sunscreen	false	Inferred relationship	Some
Zinc oxide	Is a	Drug allergen	false	Inferred relationship	Some
Zinc oxide	Is a	Zinc compound	true	Inferred relationship	Some
Zinc oxide	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Zinc	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
hamamelis- + zinkoxidsuppositorium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zinc oxide	Inferred relationship	Some
Cod liver oil 114 mg/g and zinc oxide 380 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zinc oxide	Inferred relationship	Some
Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zinc oxide	Inferred relationship	Some
salicylsyre 5 % + zinkoxid 20 % pudder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zinc oxide	Inferred relationship	Some
Product containing zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	1
Product containing starch and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing pramocaine and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing dimeticone and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing ichthammol and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing lidocaine and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Zinc compound paste BP	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zinc oxide	Inferred relationship	Some
Zinc+castor oil ointment BP	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zinc oxide	Inferred relationship	Some
lanolin 4 % + zinkoxid 8 % creme	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zinc oxide	Inferred relationship	Some
Zinc+salicylic acid paste BP	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zinc oxide	Inferred relationship	Some
zink + salicylsyre-pasta i halv styrke	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zinc oxide	Inferred relationship	Some
Product containing salicylic acid and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing castor oil and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing cod liver oil and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing calamine and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing white paraffin and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing calamine and clioquinol and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	3
lanolin + zinkoxid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zinc oxide	Inferred relationship	Some
Product containing miconazole and white petrolatum and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
miconazol 0,25 % + zinkoxid 15 % + hvid vaseline 81,35 % salve til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zinc oxide	Inferred relationship	Some
Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zinc oxide	Inferred relationship	Some
Hydrous wool fat+zinc oxide 4/8% conventional release cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Zinc oxide	Inferred relationship	Some
Cod liver oil 114 mg/g and zinc oxide 380 mg/g cutaneous ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Zinc oxide	Inferred relationship	Some	2
Cod liver oil 114 mg/g and zinc oxide 380 mg/g cutaneous ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Zinc oxide	Inferred relationship	Some	2
Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Zinc oxide	Inferred relationship	Some	1
Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Zinc oxide	Inferred relationship	Some	1
Castor oil and zinc oxide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Calamine and clioquinol and zinc oxide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	3
Product containing only zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	1
Calamine and zinc oxide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing only cod liver oil and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Dimeticone and zinc oxide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing only ichthammol and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing only white paraffin and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Miconazole and white soft paraffin and zinc oxide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing only lidocaine and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Salicylic acid and zinc oxide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing only starch and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Pramocaine and zinc oxide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Calamine- and dimeticone- and zinc oxide-containing product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	3
Cod liver oil- and zinc oxide-containing product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing calamine and dimeticone and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	3
Cod liver oil and zinc oxide only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Zinc oxide	Inferred relationship	Some	2
Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Zinc oxide	Inferred relationship	Some	2
Salicylic acid- and zinc oxide-containing product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing only calamine and dimeticone and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	3
Product containing only calamine and dimeticone and zinc oxide in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	3
Salicylic acid and zinc oxide only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing only lanolin and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Lanolin- and zinc oxide-containing product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Lanolin and zinc oxide only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing only miconazole and zinc oxide in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Miconazole nitrate 2.5 mg/g and zinc oxide 150 mg/g cutaneous ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Zinc oxide	Inferred relationship	Some	1
Miconazole nitrate 2.5 mg/g and zinc oxide 150 mg/g cutaneous ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Zinc oxide	Inferred relationship	Some	1
Product containing lanolin and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing only miconazole and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing miconazole and zinc oxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Miconazole- and zinc oxide-containing product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Zinc oxide	Inferred relationship	Some	3
Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Zinc oxide	Inferred relationship	Some	3
Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Zinc oxide	Inferred relationship	Some	2
Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Zinc oxide	Inferred relationship	Some	2
Calamine and zinc oxide only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Calamine- and zinc oxide-containing product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	2
Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Zinc oxide	Inferred relationship	Some	3
Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Zinc oxide	Inferred relationship	Some	3
Balsam of Peru and bismuth oxide and zinc oxide only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	3
Balsam of Peru- and bismuth oxide- and zinc oxide-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	3
Product containing balsam of Peru and bismuth oxide and zinc oxide in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	3
Zinc oxide-containing product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	1
Balsam of Peru and bismuth oxide and zinc oxide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Zinc oxide	Inferred relationship	Some	3

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
71494010	Zinc oxide	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
779786013	Zinc oxide (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3254891000005112	zinkoxid	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)